Navigation Links
MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
Date:7/14/2008

MOUNT LAUREL, July 14 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) today announced that its board of directors declared a dividend of $2.75 per share on MedQuist's common stock. The dividend will be paid on August 4, 2008 to shareholders of record as of the close of business on July 25, 2008.

Newcastle Partners, L.P., along with other holders of MedQuist's common stock, have filed a shareholder derivative lawsuit in the Superior Court of New Jersey, Chancery Division, seeking, among other things, to enjoin the payment of a substantial dividend. Though the court denied Newcastle's request for a temporary restraining order enjoining the declaration of the dividend, it has set July 31, 2008 as a date for a hearing regarding a preliminary injunction enjoining a substantial dividend. If the court issues the requested injunctive relief and the dividend declared by the board is enjoined, it will be paid on the first practicable business day following the lifting or expiration of the injunction.

About MedQuist:

MedQuist is the largest Medical Transcription Service Organization (MTSO) in the world, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com.

Disclosure Regarding Forward-Looking Statements:

Some of the statements in this press release constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are not historical facts but rather are based on the company's current expectations, estimates and projections regarding the company's business, operations and other factors relating thereto. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are used to identify these forward-looking statements. The forward-looking statements contained in this press release include, without limitation, statements about the timing of the payment of the declared dividend and the hearing regarding a preliminary injunction enjoining a substantial dividend. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict, including, without limitation, the risk that the settlement agreement is not consummated, the risk that the case is not dismissed with prejudice, and the risk of possible future claims against the company. For a discussion of these risks, uncertainties and assumptions, any of which could cause our actual results to differ from those contained in the forward-looking statement, see the section of the company's Annual Report on Form 10-K for the year ended December 31, 2007, entitled "Risk Factors" and discussions of potential risks and uncertainties in the MedQuist's subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
2. MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO
3. MedQuist to Get New Majority Stakeholder
4. MedQuist Technology Solutions to Power Documentation Workflow at New England Facility
5. MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation
6. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
7. MedQuist Announces Appointment of Brian ODonoghue and Mark E. Schwarz to its Board of Directors
8. MedQuist Files Preliminary Proxy Statement and Applies for Listing on NASDAQ
9. MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
10. MedQuist and MedAssets Sign Multi-Year Contract for Clinical Documentation Workflow Solutions
11. MedQuist Updates Status of Outstanding SEC Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... After raising nearly $30,000 on Kickstarter , about ... available at a discounted crowdfunding price on Indiegogo . , “Along with creating ... wanted to bring a fidget toy to the market that was made of superior ...
(Date:5/26/2017)... Illinois (PRWEB) , ... May 26, 2017 , ... Silver ... The community, which is located on more than four acres of land at 5620 ... independence. , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each ...
(Date:5/26/2017)... CA (PRWEB) , ... May 26, 2017 , ... Dr. ... is proud to announce a new, informational blog post on insurance options. If a ... checking insurance plans may help save time and money. Visiting an in-network provider for ...
(Date:5/26/2017)... ... ... to the Cross”: the personal journey of Bob Massey and his faith in the Lord. ... and Margaret Massey. Bob Massey is small in stature but big in character. ... love for others is apparent in all of his life decisions. , “I’m in ...
(Date:5/26/2017)... ... , ... “Just What Happened in the Garden of Eden”: retells the stories of three Bible ... creation of published author, Penelope Colt, mother, trader, horse farmer, artist and a former GM ... was three. At six, they moved to Dayton, Ohio, where Penny graduated high school. ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... , May 10, 2017  The Corporate ... or employees of sleep therapy clinics to call ... sleep therapy clinic is involved in a substantial ... interested in hearing from an employee of a ... in a kickback scheme to provide medical practice groups ...
(Date:5/10/2017)... CSSi, the global leader in patient recruitment, ... is proud to announce the launch of its newly ... both enriched content and a customized layout that provides ... already well-established position as the top global patient recruitment ... months of hard work, we are delighted to officially ...
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
Breaking Medicine Technology: